In the News / Politics

Food and Drug Administration (FDA) approves patisiran (Onpattro™): America’s first RNA-based therapy

By: Michael Lim, PharmD Candidate c/o 2020            In the investigation of gene function and its role in health care…

7 years ago

The expanding role of the specialty pharmacy team in care of oral oncology patients United States maternal mortality crisis: A new approach

By: Vasantha Kolluri, PharmD Candidate c/o 2019 With the recent advancement of oral oncology drugs, there has been an ever-growing…

7 years ago

Challenging the stigma of mental health

By: Mah Noor, PharmD Candidate c/o 2021 As society flourishes, life seems to grow more complex. Among the barrage of…

7 years ago

Food and Drug Administration (FDA) approves baloxavir marboxil (XOFLUZATM): first new flu drug in 20 years

By: Ruchira Kasbekar, PharmD Candidate c/o 2020 It is estimated that approximately 80,000 Americans died from the flu during the…

8 years ago

Fingolimod’s (Gilenya®) expanding role in the treatment of pediatric multiple sclerosis

By: Michael Lim, PharmD Candidate c/o 2020 In 2010, the Food and Drug Administration (FDA) approved fingolimod (Gilenya®) for the…

8 years ago

Food and Drug Administration (FDA) announces additional impurity in valsartan (Diovan®) recall

By: Karen Chen, PharmD Candidate c/o 2019 On July 13th, 2018, the U.S. Food and Drug Administration (FDA) announced a…

8 years ago

Innovation and internet outreach: the Food and Drug Administration’s (FDA) latest tactics in combatting the opioid epidemic

By: Michael Lim, PharmD Candidate c/o 2020 As the nation continues to struggle with the growing opioid epidemic, numerous organizations,…

8 years ago

Food and Drug Administration (FDA) warning about biotin interference in laboratory tests

By: Rizwan Atiq, PharmD Candidate c/o 2019 - Biotin is a nutrient that is present in certain foods and is…

8 years ago

Food and Drug Administration (FDA) approves Cassipa®: a new dosage strength sublingual film of buprenorphine and naloxone for maintenance treatment of opioid dependence

By: Maria Spilios, PharmD Candidate c/o 2019 - Opioid dependence is a major public health concern. Misuse of prescription opioids…

8 years ago

Concierge pharmacy practice: RxVIP and your future

By: Lameesa Dhanani, PharmD Candidate c/o 2019 - *Disclaimer: In November 2018, the FDA issued a Safety Communication against changing…

8 years ago